Navigation Links
International copper industry defines role in the fight against hospital infections
Date:1/5/2009

NEW YORK, NY (January 5, 2009) The copper industry is working together to answer one very important question: Can copper and copper alloys (brass and bronze) help curb the spread of bacteria that cause hospital infection? Results of laboratory testing and clinical trials indicate that they can. Scientists from around the world shared their work at the first world congress, 'Copper and Public Health', on copper's role in fighting the bacteria that cause hospital-acquired infections. The conference was held in Athens, Greece in November.

Leading scientists from the U.K., U.S., Germany and Greece, representing the disciplines of infection control, pathology, microbiology, hospital design, metallurgy and engineering, presented the scientific evidence supporting the case for incorporating copper surfaces into healthcare environments to help reduce the risk of infection and to protect public health. The first results from a clinical trial in Birmingham, England, demonstrate that the use of copper on certain surfaces on a busy hospital ward resulted in 90-100 percent fewer micro-organisms than the amount found on the control ward.

In the U.S., hospital-acquired infections claim the lives of some 100,000 people each year. The U.S. Copper Development Association (CDA) is taking a lead role in this international effort through two main initiatives: EPA registration of copper and copper alloys as antimicrobial and the initiation of clinical trials in three U.S. hospitals.

The EPA registration was granted based on independent laboratory tests demonstrating that copper, brass and bronze are more than 99.9 percent effective in killing specific disease-causing bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), one of the most virulent strains of antibiotic-resistant bacteria and a common cause of hospital- and community-acquired infections.

The clinical trials are comparing the amount of bacteria found on stainless steel, plastic and aluminum objects in intensive care units with the amount found on the same objects made of antimicrobial copper alloys, such as brass and bronze, in order to determine if copper alloys can lessen cross contamination, and perhaps lower rates of infection. The trials are funded by the U.S. Department of Defense under the aegis of the Telemedicine and Advanced Technologies Research Center (TATRC), a section of the Army Medical Research and Materiel Command (USAMRMC).


'/>"/>

Contact: Danielle McAuley
dmcauley@cda.copper.org
212-251-7209
Copper Development Association
Source:Eurekalert

Related biology news :

1. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
2. ESMO International Symposium on Immunology
3. Conservation International and Toyota partner to protect Philippines rain forests
4. International team shows mercury concentrations in fish respond quickly to increased deposition
5. International team shows mercury concentrations in fish respond quickly to increased deposition
6. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
7. Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International
8. Clemson physicist addresses international forum on thermoelectric energy
9. US launch of international consultation for new responsible nanocode
10. International team of scientists warns of climate changes impact on global river flow
11. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... ... December 04, 2019 , ... NDA Partners Chairman ... regulatory toxicology expert with more than 20 years of experience working in the ... Todd has extensive experience with a variety of biologic modalities including monoclonal antibodies, ...
(Date:11/27/2019)... ... , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center ... the ongoing efforts to promote research, educate the public, and provide support to people ...
(Date:11/19/2019)... HERCULES, Calif. (PRWEB) , ... November 19, 2019 ... ... for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and ... announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... 2019 , ... Peggy Lillis Foundation (PLF) has launched the ... C. diff. The campaign, “See C. diff,” combines basic facts and ... people in the U.S. each year. The campaign also features a portrait series ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal ... CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining ... Fusion Bx 2.0 will give urologists across Europe the ability to perform targeted ...
(Date:10/30/2019)... ... 30, 2019 , ... While using cold plasma to kill cancer cells isn’t ... School of Mines & Technology are exploring new ways to regulate cold plasma ... If successful, the technique would prove to be a drug-free, minimally invasive cancer treatment ...
(Date:10/26/2019)... ... , ... Sparks Marketing Group, Inc. (Sparks) announced ... healthcare-specific marketing firm, to strengthen the agency’s growing focus on the healthcare vertical ... in pharma, bio-therapeutics, medical device and healthcare technologies currently account for a large ...
Breaking Biology Technology: